HemoShear Therapeutics announced the appointment of John E. Reardon, Ph.D. as Head of Research and Development. The full press release is available at the link below and at hemoshear.com/press-releases/Reardon. “We are proud...

Earlier this fall, Contraline moved its operations from the University of Virginia School of Medicine into its new headquarters in Charlottesville, called “ContraLab.” ContraLab is a 2200 sq. ft. office and laboratory...

Three Charlottesville-based biotech and drug development companies that are developing exciting new technologies to cure Zika. The companies leaders (below) gathered at Indoor Biotechnologies for a forum on Zika, sharing...